Churg-Strauss syndome (multiple letters) [4]

Lancet

Volumn 353, Issue 9168, 1999, Pages 1970-1971

  Wechsler, M ^a   Drazen, J M ^a   Green, R L ^a   Vayonis, A G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; ZAFIRLUKAST; ANTIASTHMATIC AGENT; TOLUENESULFONIC ACID DERIVATIVE;

CHURG STRAUSS SYNDROME; HUMAN; LETTER; PRIORITY JOURNAL; ASTHMA; CHEMICALLY INDUCED DISORDER; NOTE;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHURG-STRAUSS SYNDROME; HUMANS; TOSYL COMPOUNDS;

EID: 0033526462     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)77180-4     Document Type: Letter

References (5)

1. RL Green AG Vayonis Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment Lancet 353 1999 725 726
2. ME Wechsler E Garpestad SR Flier Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast JAMA 279 1998 455 457
3. RS Katz M Papernik Zariflukast and Churg-Strauss syndrome JAMA 279 1998 1949
4. DL Knoell J Lucas JN Allen Churg-Strauss syndrome associated with zafirlukast Chest 114 1998 332 334
5. JG Lanham KB Elkon CD Pusey GR Hughes Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome Medicine 63 1983 65 81